2003 | Design and synthesis of A3 adenosine receptor ligands, 3′-fluoro analogues of Cl-IB-MECA | 정낙신 | Conference Paper |
2009 | Design and synthesis of N6-substituted-4′-thioadenosine-5′-uronamides as potent and selective human A3 adenosine receptor agonists | 정낙신; 최원준 | Article |
2008 | Design and synthesis of novel 2′,3′-dideoxy-4′-selenonucleosides as potential antiviral agents | 정낙신; 최원준 | Article |
2001 | Design and synthesis of novel fluorocyclopropanoid nucleosides | 정낙신 | Article; Proceedings Paper |
2008 | Design and synthesis of truncated 4'-thioadenosine derivatives as potent and selective A3 adenosine receptor antagonists. | 정낙신; 최원준 | Article |
2007 | Design, enantiopure synthesis, and biological evaluation of novel ISO-D-2′,3′-dideoxy-3′-fluorothianucleoside derivatives as a bioisostere of lamivudine | 정낙신 | Article |
2011 | Design, synthesis and anticancer activity of novel dihydrobenzofuro[4,5-b] [1,8]naphthyridin-6-one derivatives | 정낙신 | Article |
2003 | Design, synthesis and binding affinity of 3′-fluoro analogues of Cl-IB-MECA as adenosine A3 receptor ligands | 이승진; 정낙신 | Article |
2011 | Design, Synthesis, and Anti-HCV Activity of 2 '-Modified-4 '-selenonucleosides | 정낙신; 최원준; 이혁우 | Meeting Abstract |
2007 | Design, synthesis, and anti-tumor activity of 4′-thionucleosides as potent and selective agonists at the human A3 adenosine receptor | 정낙신; 이상국 | Article |
2007 | Design, synthesis, and anticancer activity of fluorocyclopentenyl-pyrimidines | 정낙신; 이상국 | Meeting Abstract |
2005 | Design, synthesis, and anticancer activity of fluorocyclopentenyl-pyrimidines. | 이강만; 정낙신; 이상국; 최원준 | Article |
2010 | Design, synthesis, and binding of homologated truncated 4′-thioadenosine derivatives at the human A3 adenosine receptors | 정낙신; 최선; 최원준 | Article |
2006 | Design, synthesis, and biological activity of N6-substituted-4′-thioadenosines at the human A3 adenosine receptor | 정낙신; 이상국 | Article |
2003 | Design, synthesis, and biological evaluation of fluoroneplanocin A as the novel mechanism-based inhibitor of S-adenosylhomocysteine hydrolase | 이강만; 정낙신; 이상국 | Article |
2007 | Design, synthesis, and biological evaluation of novel iso-d-2′,3′-dideoxy-3′-fluorothianucleoside derivatives | 정낙신 | Article |
2003 | Design, synthesis, and in vitro evaluation of APIO analogue of neplanocin A | 정낙신 | Conference Paper |
2007 | Design, synthesis, and molecular modeling studies of 5'-deoxy-5'-ureidoadenosine: 5'-ureido group as a multiple hydrogen bonding donor in the active site of S-adenosylhomocysteine hydrolase | 이강만; 정낙신; 최선 | Meeting Abstract |
2007 | Design, synthesis, and molecular modeling studies of 5′-deoxy-5′-ureidoadenosine: 5′-ureido group as multiple hydrogen bonding donor in the active site of S-adenosylhomocysteine hydrolase | 이강만; 정낙신; 최선 | Article |
2009 | Design, synthesis, antitumor activity and mode of action of novel oxiranyl and thiiranyl phenol derivatives | 정낙신 | Article |
2008 | Development of A3 adenosine receptor ligands. | 정낙신 | Article |
2009 | Development of next generation 4'-selenonucleosides. | 정낙신 | Article |
2007 | Development of novel clinical candidates targeting A(3) adenosine receptor | 정낙신 | Meeting Abstract |
2005 | Development of potent and selective human A3 adenosine receptor agonists. | 정낙신; 이상국 | Article |
2010 | Discovery of a new human A2A adenosine receptor agonist, truncated 2-hexynyl-4′-thioadenosine | 정낙신; 최선 | Article |
2007 | Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4′-thioadenosine derivatives without 4′-hydroxymethyl group as highly potent and selective antagonists | 정낙신; 이상국 | Article |
2009 | Discovery of a new template for anticancer agents: 2′-deoxy-2′- fluoro-4′-selenoarabinofuranosyl-cytosine (2′-F-4′-seleno-ara- C) | 정낙신; 이상국; 최선; 최원준 | Article |
2006 | Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor | 정낙신 | Article |
2009 | Efficient and practical synthesis of l-hamamelose | 정낙신 | Article |
2006 | Establishment of an assay for P2X7 receptor-mediated cell death | 정낙신 | Article |